Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor

INTRODUCTION: Peptides can be rationally designed as non-covalent inhibitors for molecularly targeted therapy. However, it remains challenging to efficiently deliver the peptides into the targeted cells, which often severely affects their therapeutic efficiency. METHODS: Herein, we created a novel n...

Descripción completa

Detalles Bibliográficos
Autores principales: Sui, Min, Xiong, Meimei, Li, Yuling, Zhou, Qiao, Shen, Xiaofei, Jia, Da, Gou, Maling, Sun, Qingxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054660/
https://www.ncbi.nlm.nih.gov/pubmed/33883894
http://dx.doi.org/10.2147/IJN.S266398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054660/
https://www.ncbi.nlm.nih.gov/pubmed/33883894
http://dx.doi.org/10.2147/IJN.S266398

Ejemplares similares